1. Mallinckrodt looking at a $1.6B opioid settlement plus bankruptcy for specialty generics unit —Moderna shipping coronavirus vaccine for first US trial — Novartis eye drug Beovu tied to potential vision loss — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Would you come back?

Discussion in 'ARIAD' started by Anonymous, Nov 16, 2013 at 2:13 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Agreed! bad management and egotistical leaders!
    I'd rather take my chances somewhere else!
     

  2. Anonymous

    Anonymous Guest

    AH to be sold
     
  3. Anonymous

    Anonymous Guest

    Give me a call! I have been out of work for almost a year! I can put up with ANYTHING at this point!
     
  4. Anonymous

    Anonymous Guest

    For all the haters of ariad.....Call me. I will gladly put up with Q, Hilman, Purdy, and the others...When you get the carpet pulled out from under your feet for no reason, working for them would be a picnic...Just remember that and I truly hope that never happens to you!
     
  5. Anonymous

    Anonymous Guest

    One of the "desparate" ones!
     
  6. Anonymous

    Anonymous Guest

    I understand where you are coming from but it's hard to work for a company with egotistical morons at the helm.
     
  7. Anonymous

    Anonymous Guest

    Pull your teeth and blow me! You are goddamned right I am desperate ! Fuck nuts!
     
  8. Anonymous

    Anonymous Guest

    Heisenberg
     
  9. Anonymous

    Anonymous Guest

    No way. Culture blew and drug did too. Good riddance. Got a new gig anyway recently.
     
  10. Anonymous

    Anonymous Guest

    Will Novartis Oncology suffer now since there are reports of blood clots with Tasigna as well? Interesting how Ariad trials were done with pts who failed with Novartis drugs and blood clots occurred.
     
  11. Anonymous

    Anonymous Guest

    And you are hanging your hat on this? Get a life! Or are you one of the "desparate" ones?
     
  12. Anonymous

    Anonymous Guest

    Nope!

    Harvey Berger, Ariad Pharmaceuticals

    Years ago, Berger was one of the more despised CEOs in bio-pharma. He was viewed as a self-serving bully with an anger problem. At one point in 2008, the independent directors serving on Ariad's board resigned because of Berger. Then Ariad started to develop the leukemia drug ponatinib and the results were impressive. Wall Street investors held their nose and bought Ariad stock, hoping Berger wouldn't screw up a good thing.

    For awhile, the strategy worked really well. Ponatinib advanced through clinical trials and was granted FDA approval in December 2012. Ariad's stock price soared, investors were happy. Berger toned down his act and even seemed on a path of redemption.

    But no. Call it reversion to the mean, bad luck or both, but Berger's behavior and decision making disintegrated in 2013. The toxicity and side effects associated with ponatinib (now known as Iclusig) became an issue soon after the drug was launched in January. On conference calls, Berger lashed out at critics or seemed defensive. He made excuses for selling Ariad stock. Worst of all (and unknown to investors) Berger was engaged in a fight with the FDA over the agency's growing concerns about blood clots and other heart safety side effects tied to Iclusig. Refusing to cooperate with FDA, particularly when the fight involves serious drug toxicity and the safety of patients is a losing game.

    Berger lost. Ariad's patients, employees and shareholders lost too. And once again, Berger is one of the most despised CEO in bio-pharma.
     
  13. Anonymous

    Anonymous Guest

    Would Pfizer buy Ariad?
     
  14. Anonymous

    Anonymous Guest

    Not no, but Hail No!
     
  15. Anonymous

    Anonymous Guest

    Pfizer is still saying WTF from the King deal. If they had money to spend, I'd think they'd have other options.
     
  16. Anonymous

    Anonymous Guest


    Yeah, sure they would.
     
  17. anonymous

    anonymous Guest

    old thread here- but holy cow, that you tube link to George Carlin! I think Trump must have been chnneling him during the campaign!!